financetom
Business
financetom
/
Business
/
Almaden Minerals Secures Up to US$9.5 Million in Litigation Financing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Almaden Minerals Secures Up to US$9.5 Million in Litigation Financing
Jun 27, 2024 5:36 AM

08:17 AM EDT, 06/27/2024 (MT Newswires) -- Almaden Minerals ( AAUAF ) , which fell 19% on Wednesday to a 52-week low, on Thursday confirmed it has secured non-recourse litigation funding of up to US$9.5 million to pursue its arbitration proceedings against Mexico under the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP).

The proceedings arise from Mexico blocking the development of the Ixtaca project and retroactively terminating Almaden's mineral concessions there. The actions also impacted Almadex Minerals ( AAMMF ) , which held a 2% net smelter returns royalty on the project.

Almaden has agreed with Almadex to extend the maturity of its gold loan from March 31, 2026 to either March 31, 2030, or when Almaden receives any proceeds from its claims against Mexico (whichever is the earlier). In return, Almaden will pay Almadex 2% of the gross amount of any damages award that it may receive as a result of the legal claims, subject to certain conditions.

Almaden will also "streamline" management of the arbitration proceedings via a litigation management agreement. It will bear the up-front costs of the arbitration and provide overall direction to the arbitration process, including for Almadex Minerals ( AAMMF ).

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
China's Tencent Music Sees Shrinking Audience Even As Paying Users Rise
China's Tencent Music Sees Shrinking Audience Even As Paying Users Rise
Mar 17, 2026
Tencent Music Entertainment ( TME ) shares slid on Tuesday after the company posted fourth-quarter results. Revenue came in at $1.24 billion, up 15.9% year-over-year (Y/Y), driven by robust growth in online music services. Analysts had projected $1.20 billion. China's online music and audio entertainment platform's adjusted EPADS of 23 cents (1.60 Chinese yuan) topped the analyst consensus estimate of 21 cents. Subscription Momentum...
Trans Canada Gold Announcing Expanded Gold Potential While Co Prepares for Exploration and Drilling on its Harrison Lake Gold Project
Trans Canada Gold Announcing Expanded Gold Potential While Co Prepares for Exploration and Drilling on its Harrison Lake Gold Project
Mar 17, 2026
08:22 AM EDT, 03/17/2026 (MT Newswires) -- Trans Canada Gold Corp. ( TTGXF ) , which saw its shares drop near 10% yesterday, provided Tuesday a corporate update on the Harrison Lake Gold Project as it prepares for its upcoming 2026 drilling plans on the Gold Project. It said the project is demonstrating the same geological characteristics as the Snowline...
American Airlines flags $400 million cost impact due to jet fuel price spike
American Airlines flags $400 million cost impact due to jet fuel price spike
Mar 17, 2026
March 17 (Reuters) - American Airlines ( AAL ) said on Tuesday it expects a $400 million increase in first-quarter expenses as jet fuel prices surge due to the Middle East conflict. (Reporting by Shivansh Tiwary in Bengaluru; Editing by Sriraj Kalluvila) ...
Eupraxia Pharmaceuticals Says Eosinophilic Esophagitis Treatment Trial Shows Over Half of Patients in Remission
Eupraxia Pharmaceuticals Says Eosinophilic Esophagitis Treatment Trial Shows Over Half of Patients in Remission
Mar 17, 2026
08:21 AM EDT, 03/17/2026 (MT Newswires) -- Eupraxia Pharmaceuticals ( EPRX ) said Tuesday data from its ongoing trial evaluating EP-104GI for eosinophilic esophagitis treatment showed 59% of patients achieved clinical remission at 12 weeks. At 24 weeks, 76% of the patients maintained clinical remission, Eupraxia said. No serious adverse events have been reported, and the drug continues to be...
Copyright 2023-2026 - www.financetom.com All Rights Reserved